Literature DB >> 23371953

Preemptive deceased donor kidney transplantation: considerations of equity and utility.

Morgan E Grams1, B Po-Han Chen, Josef Coresh, Dorry L Segev.   

Abstract

BACKGROUND AND OBJECTIVES: There exists gross disparity in national deceased donor kidney transplant availability and practice: waiting times exceed 6 years in some regions, but some patients receive kidneys before they require dialysis. This study aimed to quantify and characterize preemptive deceased donor kidney transplant recipients and compare their outcomes with patients transplanted shortly after dialysis initiation. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Using the Scientific Registry of Transplant Recipients database, first-time adult deceased donor kidney transplant recipients between 1995 and 2011 were classified as preemptive, early (on dialysis ≤1 year), or late recipients. Random effects logistic regression and multivariate Cox proportional hazards regression were used to identify characteristics of preemptive deceased donor kidney transplant and evaluate survival in preemptive and early recipients, respectively.
RESULTS: Preemptive recipients were 9.0% of the total recipient population. Patients with private insurance (adjusted odds ratio=3.15, 95% confidence interval=3.01-3.29, P<0.001), previous (nonkidney) transplant (adjusted odds ratio=1.94, 95% confidence interval=1.67-2.26, P<0.001), and zero-antigen mismatch (adjusted odds ratio=1.45, 95% confidence interval=1.37-1.54, P<0.001; Caucasians only) were more likely to receive preemptive deceased donor kidney transplant, even after accounting for center-level clustering. African Americans were less likely to receive preemptive deceased donor kidney transplant (adjusted odds ratio=0.44, 95% confidence interval=0.41-0.47, P<0.001). Overall, patients transplanted preemptively had similar survival compared with patients transplanted within 1 year after initiating dialysis (adjusted hazard ratio=1.06, 95% confidence interval=0.99-1.12, P=0.07).
CONCLUSIONS: Preemptive deceased donor kidney transplant occurs most often among Caucasians with private insurance, and survival is fairly similar to survival of recipients on dialysis for <1 year.

Entities:  

Mesh:

Year:  2013        PMID: 23371953      PMCID: PMC3613950          DOI: 10.2215/CJN.05310512

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  27 in total

1.  Deleterious effect of waiting time on renal transplant outcome.

Authors:  H Meier-Kriesche; F K Port; A O Ojo; A B Leichtman; S M Rudich; J A Arndorfer; J D Punch; B Kaplan
Journal:  Transplant Proc       Date:  2001 Feb-Mar       Impact factor: 1.066

2.  Dialysis prior to living donor kidney transplantation and rates of acute rejection.

Authors:  Kevin C Mange; Marshall M Joffe; Harold I Feldman
Journal:  Nephrol Dial Transplant       Date:  2003-01       Impact factor: 5.992

3.  Effect of the use or nonuse of long-term dialysis on the subsequent survival of renal transplants from living donors.

Authors:  K C Mange; M M Joffe; H I Feldman
Journal:  N Engl J Med       Date:  2001-03-08       Impact factor: 91.245

4.  Perioperative mortality and long-term survival following live kidney donation.

Authors:  Dorry L Segev; Abimereki D Muzaale; Brian S Caffo; Shruti H Mehta; Andrew L Singer; Sarah E Taranto; Maureen A McBride; Robert A Montgomery
Journal:  JAMA       Date:  2010-03-10       Impact factor: 56.272

Review 5.  Racial equity in renal transplantation. The disparate impact of HLA-based allocation.

Authors:  R S Gaston; I Ayres; L G Dooley; A G Diethelm
Journal:  JAMA       Date:  1993-09-15       Impact factor: 56.272

6.  Access to kidney transplantation. Has the United States eliminated income and racial differences?

Authors:  P J Held; M V Pauly; R R Bovbjerg; J Newmann; O Salvatierra
Journal:  Arch Intern Med       Date:  1988-12

7.  Kidneys from deceased donors: maximizing the value of a scarce resource.

Authors:  Herwig-Ulf Meier-Kriesche; Jesse D Schold; Robert S Gaston; Jonas Wadstrom; Bruce Kaplan
Journal:  Am J Transplant       Date:  2005-07       Impact factor: 8.086

8.  Effect of HLA matching on organ distribution among whites and African-Americans.

Authors:  A A Zachary; W E Braun; J M Hayes; J B McElroy; A C Novick; J A Schulak; W V Sharp
Journal:  Transplantation       Date:  1994-04-15       Impact factor: 4.939

9.  The effects of DonorNet 2007 on kidney distribution equity and efficiency.

Authors:  A B Massie; S L Zeger; R A Montgomery; D L Segev
Journal:  Am J Transplant       Date:  2009-05-20       Impact factor: 8.086

10.  Age and comorbidities are effect modifiers of gender disparities in renal transplantation.

Authors:  Dorry L Segev; Lauren M Kucirka; Pooja C Oberai; Rulan S Parekh; L Ebony Boulware; Neil R Powe; Robert A Montgomery
Journal:  J Am Soc Nephrol       Date:  2009-01-07       Impact factor: 10.121

View more
  19 in total

1.  Living Donor Kidney Transplantation: Facilitating Education about Live Kidney Donation--Recommendations from a Consensus Conference.

Authors:  Jane C Tan; Elisa J Gordon; Mary Amanda Dew; Dianne LaPointe Rudow; Robert W Steiner; E Steve Woodle; Rebecca Hays; James R Rodrigue; Dorry L Segev
Journal:  Clin J Am Soc Nephrol       Date:  2015-04-23       Impact factor: 8.237

2.  Association Between Medicaid Expansion Under the Affordable Care Act and Medicaid-Covered Pre-emptive Kidney Transplantation.

Authors:  Meera N Harhay; Ryan M McKenna; Michael O Harhay
Journal:  J Gen Intern Med       Date:  2019-11       Impact factor: 5.128

3.  Reassessing Preemptive Kidney Transplantation in the United States: Are We Making Progress?

Authors:  Colleen L Jay; Patrick G Dean; Ryan A Helmick; Mark D Stegall
Journal:  Transplantation       Date:  2016-05       Impact factor: 4.939

4.  Graft and patient survival outcomes of a third kidney transplant.

Authors:  Robert R Redfield; Meera Gupta; Eduardo Rodriguez; Alexander Wood; Peter L Abt; Matthew H Levine
Journal:  Transplantation       Date:  2015-02       Impact factor: 4.939

5.  Association of the kidney allocation system with dialysis exposure before deceased donor kidney transplantation by preemptive wait-listing status.

Authors:  Meera N Harhay; Michael O Harhay; Karthik Ranganna; Suzanne M Boyle; Lissa Levin Mizrahi; Stephen Guy; Gregory E Malat; Gary Xiao; David J Reich; Rachel E Patzer
Journal:  Clin Transplant       Date:  2018-09-15       Impact factor: 2.863

6.  Racial disparities in preemptive referral for kidney transplantation in Georgia.

Authors:  Jennifer C Gander; Xingyu Zhang; Laura Plantinga; Sudeshna Paul; Mohua Basu; Stephen O Pastan; Eric Gibney; Erica Hartmann; Laura Mulloy; Carlos Zayas; Rachel E Patzer
Journal:  Clin Transplant       Date:  2018-08-26       Impact factor: 2.863

7.  Persistent Disparities in Preemptive Kidney Transplantation.

Authors:  Tanjala S Purnell; Deidra C Crews
Journal:  Clin J Am Soc Nephrol       Date:  2019-09-26       Impact factor: 8.237

8.  Kidney transplant referral practices in southeastern dialysis units.

Authors:  Teri Browne; Rachel E Patzer; Jennifer Gander; M Ahinee Amamoo; Jenna Krisher; Leighann Sauls; Stephen Pastan
Journal:  Clin Transplant       Date:  2016-02-12       Impact factor: 2.863

9.  Initiating Maintenance Dialysis Before Living Kidney Donor Transplantation When a Donor Candidate Evaluation Is Well Underway.

Authors:  Steven Habbous; Eric McArthur; Stephanie N Dixon; Susan McKenzie; Carlos Garcia-Ochoa; Ngan N Lam; Krista L Lentine; Christine Dipchand; Kenneth Litchfield; Mehmet A Begen; Sisira Sarma; Amit X Garg
Journal:  Transplantation       Date:  2018-07       Impact factor: 4.939

10.  Inequity in Access to Transplantation in the United Kingdom.

Authors:  Rishi Pruthi; Matthew L Robb; Gabriel C Oniscu; Charles Tomson; Andrew Bradley; John L Forsythe; Wendy Metcalfe; Clare Bradley; Christopher Dudley; Rachel J Johnson; Christopher Watson; Heather Draper; Damian Fogarty; Rommel Ravanan; Paul J Roderick
Journal:  Clin J Am Soc Nephrol       Date:  2020-05-28       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.